Abstract: Some embodiments of the disclosure provide a method for measuring lesion features of hypertensive retinopathy. In some examples, the method includes: acquiring a fundus image (s110); identifying an optic disc region of the fundus image and dividing the fundus image into at least three regions including a first region (c1), a second region (c2), and a third region (c3) on the basis of the optic disc region (b) (s120); performing artery and vein segmentation on the fundus image by a deep learning-based arteriovenous segmentation model to obtain the arteriovenous segmentation result (s130), the arteriovenous vessel annotation results including an artery annotation result (e1), a vein annotation result (e2), and a small vessel annotation result (e3); and measuring lesion features in the fundus image on the basis of the three regions (c1, c2, c3) and the arteriovenous segmentation result (s140).

Abstract: A pleuromutilin cinnamic acid ester compound with activities against antibiotic-resistant infections having the following formula (I) R1, R2, R3, R4 and R5 are independently hydrogen, halogen, nitro, cyano, methoxy, trifluoromethyl, benzyloxy, aryl or dimethylamino.

Abstract: A pleuromutilin cinnamic acid ester compound with activities against antibiotic-resistant infections having the following formula (I) R1, R2, R3, R4 and R5 are independently hydrogen, halogen, nitro, cyano, methoxy, trifluoromethyl, benzyloxy, aryl or dimethylamino.

Abstract: An optically pumped on-chip solid-state laser includes a solid gain media substrate and a laser generating structure disposed above the solid gain media substrate. The laser generating structure includes a resonator, a pump light input structure, and a laser light output structure; and the resonator is disposed between the pump light input structure and the laser light output structure, and is propped against or is in clearance fit with the solid gain media substrate.

Abstract: A compound of formula I or formula II, a pharmaceutically acceptable salt, or a tautomer thereof is disclosed. The Linker is or and n is 1-6.

Abstract: A compound of formula I or formula II, a pharmaceutically acceptable salt, or a tautomer thereof is disclosed. In formula I and II, n is 1-6.

Abstract: Methods, computer program products, and systems are presented. The method computer program products, and systems can include, for instance: collecting logging data generated by operation of a distributed computing system that is used by a plurality of tenants; storing the logging data as a plurality of files stored in a multi tier, shared volume storage system, with the storage of the logging data as a plurality of files including: dividing the plurality of files among and between a plurality of shared volume data structures, and organizing each shared volume data structure of the plurality of shared volume data structures according to a plurality of tiers; for each given file of the plurality of files; and mapping, by a domain agent and in a mapping table data structure, an association between the given file and the shared volume data structure in which the given file is stored.

Abstract: A compound of Formula I: is disclosed. A method of preparing the compound of Formula I is also disclosed. R is alkyl, haloalkyl, aryl, or substituted aryl.

Abstract: Methods, computer program products, and systems are presented. The method computer program products, and systems can include, for instance: collecting logging data generated by operation of a distributed computing system that is used by a plurality of tenants; storing the logging data as a plurality of files stored in a multi tier, shared volume storage system, with the storage of the logging data as a plurality of files including: dividing the plurality of files among and between a plurality of shared volume data structures, and organizing each shared volume data structure of the plurality of shared volume data structures according to a plurality of tiers; for each given file of the plurality of files; and mapping, by a domain agent and in a mapping table data structure, an association between the given file and the shared volume data structure in which the given file is stored.

Abstract: A compound of chemical formula I: or chemical formula II: or a pharmaceutical acceptable salt thereof is disclosed. R1, R2, R3, and R4 are independently H, halogen, nitro, hydroxyl, cyano, benzyloxy, C1-C8 straight or branched alkyl, C1-C8 straight or branched haloalkyl, C1-C8 straight or branched alkoxy.

Abstract: A compound of chemical formula I: or formula II: or a pharmaceutical acceptable salt thereof is disclosed. R1 is OH or OAc; X is C or N; and R2 is H, alkyl, alkoxy, benzyloxy, haloalkyl, OH, CN, NO2, or halogen, provided that when X is N, R2 is nil.

Abstract: A compound having the following formula I: is disclosed. A method of preparing the compound of formula I is also disclosed.

Abstract: A method of preparing 6-chloro-5-nitro-2,4-diaminopyrimidine includes: reacting guanidine hydrochloride with ethyl carbamoylacetate and sodium hypochlorite in the presence of a metal nitrate salt and acetate anhydride in an organic solvent.

Abstract: A compound of chemical formula I: or chemical formula II: or a pharmaceutical acceptable salt thereof is disclosed. R1, R2, R3, and R4 are independently H, halogen, nitro, hydroxyl, cyano, benzyloxy, C1-C8 straight or branched alkyl, C1-C8 straight or branched haloalkyl, C1-C8 straight or branched alkoxy.

Abstract: A compound of chemical formula I or a pharmaceutical acceptable salt thereof is disclosed. R1 is OH or OAc; X is C or N; and R2 is H, alkyl, alkoxy, benzyloxy, haloalkyl, OH, CN, NO2, or halogen, provided that when X is N, R2 is nil.

Abstract: A network interface terminal (“NIT”) able to provide network service includes an intrusion shrapnel, elastic element, intrusion plate, and bolt is disclosed. The intrusion shrapnel, in one embodiment, has a cylindrical body with an opening through center of the cylindrical body. First and second discs are attached to each end of the cylindrical body. The elastic element, such as a spring, is situated between the first disc and a frame applying a force pulling the intrusion shrapnel in a disengaging direction. The intrusion plate which is electrically coupled to a PCB is situated adjacent to the second disc. The bolt having a helical ridge thread passes through the open of the cylindrical body and makes the second disc to electrically contact with the intrusion plate.

Abstract: A network interface terminal (“NIT”) able to provide network service includes an intrusion shrapnel, elastic element, intrusion plate, and bolt is disclosed. The intrusion shrapnel, in one embodiment, has a cylindrical body with an opening through center of the cylindrical body. First and second discs are attached to each end of the cylindrical body. The elastic element, such as a spring, is situated between the first disc and a frame applying a force pulling the intrusion shrapnel in a disengaging direction. The intrusion plate which is electrically coupled to a PCB is situated adjacent to the second disc. The bolt having a helical ridge thread passes through the open of the cylindrical body and makes the second disc to electrically contact with the intrusion plate.